Quantcast

Latest Halozyme Therapeutics Inc. Stories

2015-05-27 08:34:25

SAN DIEGO, May 27, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc. (NASDAQ: HALO) and Ventana Medical Systems, Inc.

2015-05-11 16:33:36

- Revenues increase 56 percent to $18.7 million, loss narrows to $15.1 million - SAN DIEGO, May 11, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2015-05-07 16:31:29

SAN DIEGO, May 7, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2015-04-20 08:31:34

Data to support ongoing work with Halozyme's investigational new drug PEGPH20 in combination with immuno-oncology agents SAN DIEGO, April 20, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2015-04-08 08:31:51

Recent FDA meeting allows for potential marketing application based on progression free survival in pivotal Phase 3 pancreatic cancer study SAN DIEGO, April 8, 2015 /PRNewswire/ -- Halozyme

2015-03-10 08:35:43

SAN DIEGO, March 10, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2015-03-03 16:28:49

SAN DIEGO, March 3, 2015 /PRNewswire/ -- Halozyme Therapeutics, Inc.

2015-03-02 16:31:25

- Study 202 interim results presented, evaluating investigational new drug PEGPH20 with gemcitabine and ABRAXANE® (nab-paclitaxel) in Stage IV pancreatic cancer patients - SAN DIEGO, March

2015-02-23 16:31:28

SAN DIEGO, Feb. 23, 2015 /PRNewswire/ --Halozyme Therapeutics, Inc.

2015-02-17 08:34:45

- Data highlights the use and potential of PEGPH20 to enhance the anti-cancer activity of monoclonal antibodies and NK cell access in breast and ovarian cancer preclinical models - SAN DIEGO,


Word of the Day
begunk
  • To befool; deceive; balk; jilt.
  • An illusion; a trick; a cheat.
The word 'begunk' may come from a nasalised variant of Scots begeck ("to deceive, disappoint"), equivalent to be- +‎ geck.